Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Paramount Global Income Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Revenue	0.66	0.7	0.87	1.3	0.98	0.72
Revenue Growth (YoY)	0.78%	-19.11%	-33.22%	32.49%	36.57%	-44.44%
Cost of Revenue	0.23	0.25	0.32	0.4	0.52	0.54
Gross Profit	0.42	0.45	0.55	0.9	0.46	0.18
Selling, General & Admin	0.7	0.72	0.91	0.9	0.92	1.03
Operating Expenses	0.81	0.84	1.02	1.01	1.03	1.14
Operating Income	-0.38	-0.38	-0.47	-0.11	-0.57	-0.96
Interest Expense	-0.01	-0.01	-0.03	-0.01	-0	-
Interest & Investment Income	-	-	-	-	-	0
Currency Exchange Gain (Loss)	-0.02	-0.01	-0.01	-0.01	-	-
Other Non Operating Income (Expenses)	-0.06	-0.06	-0.03	-0.02	-0.05	-0.04
EBT Excluding Unusual Items	-0.47	-0.46	-0.55	-0.15	-0.62	-0.99
Other Unusual Items	-	-	-	-	0.02	0.14
Pretax Income	-0.47	-0.46	-0.55	-0.15	-0.6	-0.85
Net Income	-0.47	-0.46	-0.55	-0.15	-0.6	-0.85
Net Income to Common	-0.47	-0.46	-0.55	-0.15	-0.6	-0.85
Shares Outstanding (Basic)	69	69	69	69	69	69
Shares Outstanding (Diluted)	69	69	69	69	69	69
EPS (Basic)	-0.01	-0.01	-0.01	-0.00	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01	-0.00	-0.01	-0.01
Free Cash Flow	-0.01	-0.02	-0.02	-0.01	-0.12	-0.54
Free Cash Flow Per Share	-	-	-	-	-0.00	-0.01
Gross Margin	64.53%	64.72%	63.18%	69.45%	46.72%	25.00%
Operating Margin	-58.21%	-54.24%	-54.42%	-8.60%	-58.07%	-133.15%
Profit Margin	-71.44%	-64.93%	-62.98%	-11.53%	-61.52%	-118.67%
Free Cash Flow Margin	-1.28%	-2.17%	-1.95%	-0.56%	-12.41%	-75.55%
EBITDA	-0.34	-0.33	-0.42	-0.06	-0.52	-0.91
EBITDA Margin	-52.20%	-47.43%	-48.87%	-4.97%	-53.42%	-126.75%
D&A For EBITDA	0.04	0.05	0.05	0.05	0.05	0.05
EBIT	-0.38	-0.38	-0.47	-0.11	-0.57	-0.96
EBIT Margin	-58.21%	-54.24%	-54.42%	-8.60%	-58.07%	-133.15%
Revenue as Reported	0.66	0.7	0.87	1.3	0.98	0.72
Advertising Expenses	-	0	0	0	0.02	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.